Rallybio and J&J collaborate to tackle maternal-foetal blood disorder
The collaboration pact will see Rallybio gaining a $6.6m equity investment from J&J to further a natural history study of FNAIT.
The collaboration pact will see Rallybio gaining a $6.6m equity investment from J&J to further a natural history study of FNAIT.
What's Your Reaction?
